Vivus

News

Obesity Drugs: The Road to Perdition

TheStreet.com

News

5 Drugmakers Headed Back to the Drawing Board

Motley Fool

News

A Foursome Of Pharma Earnings Suggests Business Is Still Tough

Investopedia

News

Arena's Obese To-Do List

Motley Fool

News

Rats Plague Arena's Diet Pill

Minyanville

News

Biotech Stock Mailbag: Orexigen Therapeutics

TheStreet.com

News

Vivus says FDA asks about Qnexa birth defect link

Yahoo/AP

News

Smart Money's 9 Top Biotech Stock Picks

Seeking Alpha

News

Vivus Says Erection Drug Works in 80 Percent of Men

Bloomberg

News

2011 Drugmaker M&A Targets

Motley Fool